We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
Cap. Flow
-$145M
Cap. Flow %
-0.21%
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$374M
2
FE icon
FirstEnergy
FE
+$348M
3
ALL icon
Allstate
ALL
+$267M
4
SNY icon
Sanofi
SNY
+$259M
5
JPM icon
JPMorgan Chase
JPM
+$256M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$603M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$561M
3
NVS icon
Novartis
NVS
+$233M
4
KLAC icon
KLA
KLAC
+$233M
5
UNH icon
UnitedHealth
UNH
+$207M

Sector Composition

Rank Sector Weight
1 Financials 18.86%
2 Healthcare 17.72%
3 Industrials 14.6%
4 Technology 13.23%
5 Energy 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COWN
776
DELISTED
Cowen Inc. Class A Common Stock
COWN
-24,646
Closed -$584K
WLL
777
DELISTED
Whiting Petroleum Corporation
WLL
-1,430,102
Closed -$97.3M
OZON
778
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$0 ﹤0.01%
75,213
HHR
779
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$0 ﹤0.01%
24,536

Similar funds

Boston Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
  • Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
  • Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
  • Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
  • Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
  • Boston Partners opened 72 new positions and closed 59 in Q3 2022.
  • Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.

Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.